Perrigo | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
AbbVie USD 5.52B 1.73B 2024-12
Abbott USD 6.53B 1.08B 2025-03
Bayer EUR 4.02B 2.18B 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Corcept Therapeutics USD 89.82M 37.85M 2025-03
Dr.Reddys Laboratories INR 14.65B 1.62B 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
J&J USD 38.47B 32.35B 2025-03
Merck USD 8.63B 4.61B 2025-03
Nestle CHF 5.56B 691M 2024-12
Pacira USD 283.61M 6.84M 2025-03
Perrigo USD 409.9M 148.9M 2025-03
Pfizer USD 1.43B 387M 2025-03
Prestige Brands USD 97.88M 47.01M 2025-03
Reckitt Benckiser GBP 880M 106M 2024-12
Sanofi 7.99B 550M 2025-03
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12
Teva Pharmaceutical Industries USD 1.7B 1.6B 2025-03
Xeris Pharmaceuticals USD 71.62M 12.39M 2024-12
Zoetis USD 1.72B 264M 2025-03



Perrigo Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.